Bo Nordenskjöld

PIK3CA Mutations and PTEN Loss Correlate with Similar Prognostic Factors and Are Not Mutually Exclusive in Breast Cancer

Gizeh Pérez‐Tenorio, Liza Alkhori, Birgit Olsson et al. · Clinical Cancer Research · 2007 · 293 citations

Medicine, Genetics, Oncology +17

Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

Pia Wegman, Elingarami Sauli, John Carstensen et al. · Breast Cancer Research · 2007 · 286 citations · Full text

Medicine, Genetics, Oncology +14

Effects of Hydroxyurea and 1‐β‐D‐Arabinofuranosyl‐cytosine on Deoxyribonucleotide Pools in Mouse Embryo Cells

Lambert Skoog, Bo Nordenskjöld · European Journal of Biochemistry · 1971 · 279 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

Pia Wegman, Linda Vainikka, Olle Stål et al. · Breast Cancer Research · 2005 · 243 citations · Full text

Medicine, Biochemistry, Oncology +14

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

P-L Jerevall, X-J Ma, Huan Li et al. · British Journal of Cancer · 2011 · 227 citations · Full text

Medicine, Biostatistics, Oncology +16